Clinical trial
Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic…
NCT00231257 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00231257 |
|---|---|
| Title | Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR) |
| Official title | A Multicenter, Randomized Study of the Sirolimus-Eluting Bx VELOCITY® BALLOON Expandable Stent vs. Intravascular Brachytherapy in the Treatment of Patients With In-Stent Restenotic Coronary Artery Lesions |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | In-Stent Restenosis |
| Intervention type | Device, Procedure |
| Interventions | Sirolimus-Eluting Bx Velocity® Balloon Expandable Stent, Brachytherapy |
| Enrollment | 384 |
| Start date | Feb 1, 2003 |
| Primary completion | Jan 1, 2005 |
| Completion | Sep 1, 2009 |
| First posted | Oct 4, 2005 |
| Last update posted | Nov 19, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: